These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
749 related articles for article (PubMed ID: 32434573)
1. Antifibrotic therapy to normalize the tumor microenvironment. Hauge A; Rofstad EK J Transl Med; 2020 May; 18(1):207. PubMed ID: 32434573 [TBL] [Abstract][Full Text] [Related]
2. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance. Dzobo K; Dandara C OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970 [TBL] [Abstract][Full Text] [Related]
3. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Takai K; Le A; Weaver VM; Werb Z Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881 [TBL] [Abstract][Full Text] [Related]
4. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899 [TBL] [Abstract][Full Text] [Related]
5. Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts. Shi X; Young CD; Zhou H; Wang X Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33322749 [TBL] [Abstract][Full Text] [Related]
6. Breaking Physical Barrier of Fibrotic Breast Cancer for Photodynamic Immunotherapy by Remodeling Tumor Extracellular Matrix and Reprogramming Cancer-Associated Fibroblasts. Qiu ZW; Zhong YT; Lu ZM; Yan N; Kong RJ; Huang JQ; Li ZF; Nie JM; Li R; Cheng H ACS Nano; 2024 Apr; 18(13):9713-9735. PubMed ID: 38507590 [TBL] [Abstract][Full Text] [Related]
7. TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment. Chung JY; Chan MK; Li JS; Chan AS; Tang PC; Leung KT; To KF; Lan HY; Tang PM Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299192 [TBL] [Abstract][Full Text] [Related]
8. Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis. Zhang W; Wang J; Liu C; Li Y; Sun C; Wu J; Wu Q J Transl Med; 2023 Nov; 21(1):827. PubMed ID: 37978384 [TBL] [Abstract][Full Text] [Related]
9. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways. Yoshida GJ J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182 [TBL] [Abstract][Full Text] [Related]
10. Targeting ROCK2 improves macromolecular permeability in a 3D fibrotic pancreatic cancer microenvironment model. Tanaka HY; Nakazawa T; Miyazaki T; Cabral H; Masamune A; Kano MR J Control Release; 2024 May; 369():283-295. PubMed ID: 38522816 [TBL] [Abstract][Full Text] [Related]
11. Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance. Tajaldini M; Poorkhani A; Amiriani T; Amiriani A; Javid H; Aref P; Ahmadi F; Sadani S; Khori V Eur J Pharmacol; 2023 Oct; 957():175991. PubMed ID: 37619785 [TBL] [Abstract][Full Text] [Related]
12. The role of cancer-associated fibroblasts in breast cancer pathobiology. Jung YY; Kim HM; Koo JS Histol Histopathol; 2016 Apr; 31(4):371-8. PubMed ID: 26627101 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β modulates pancreatic cancer associated fibroblasts cell shape, stiffness and invasion. Stylianou A; Gkretsi V; Stylianopoulos T Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1537-1546. PubMed ID: 29477748 [TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix (ECM) stiffness and degradation as cancer drivers. Najafi M; Farhood B; Mortezaee K J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449 [TBL] [Abstract][Full Text] [Related]
15. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Wu F; Yang J; Liu J; Wang Y; Mu J; Zeng Q; Deng S; Zhou H Signal Transduct Target Ther; 2021 Jun; 6(1):218. PubMed ID: 34108441 [TBL] [Abstract][Full Text] [Related]
16. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Yang M; Li J; Gu P; Fan X Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371 [TBL] [Abstract][Full Text] [Related]
17. The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases. Giguelay A; Turtoi E; Khelaf L; Tosato G; Dadi I; Chastel T; Poul MA; Pratlong M; Nicolescu S; Severac D; Adenis A; Sgarbura O; Carrère S; Rouanet P; Quenet F; Ychou M; Pourquier D; Colombo PE; Turtoi A; Colinge J Theranostics; 2022; 12(17):7624-7639. PubMed ID: 36438498 [No Abstract] [Full Text] [Related]
18. Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment. Zhang J; Fan J; Zeng X; Nie M; Luan J; Wang Y; Ju D; Yin K Acta Pharm Sin B; 2021 Mar; 11(3):609-620. PubMed ID: 33777671 [TBL] [Abstract][Full Text] [Related]
19. TGF-β Mediated Immune Evasion in Cancer-Spotlight on Cancer-Associated Fibroblasts. Ghahremanifard P; Chanda A; Bonni S; Bose P Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291370 [TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Islam MS; Ciavattini A; Petraglia F; Castellucci M; Ciarmela P Hum Reprod Update; 2018 Jan; 24(1):59-85. PubMed ID: 29186429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]